Annual Gross Profit
$460.47 M
+$143.89 M+45.45%
31 December 2023
Summary:
Evolent Health annual gross profit is currently $460.47 million, with the most recent change of +$143.89 million (+45.45%) on 31 December 2023. During the last 3 years, it has risen by +$210.06 million (+83.89%). EVH annual gross profit is now at all-time high.EVH Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Gross Profit
$80.69 M
-$26.15 M-24.48%
30 September 2024
Summary:
Evolent Health quarterly gross profit is currently $80.69 million, with the most recent change of -$26.15 million (-24.48%) on 30 September 2024. Over the past year, it has dropped by -$20.93 million (-20.60%). EVH quarterly gross profit is now -35.15% below its all-time high of $124.43 million, reached on 30 September 2023.EVH Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Gross Profit
$393.27 M
-$43.74 M-10.01%
30 September 2024
Summary:
Evolent Health TTM gross profit is currently $393.27 million, with the most recent change of -$43.74 million (-10.01%) on 30 September 2024. Over the past year, it has dropped by -$67.20 million (-14.59%). EVH TTM gross profit is now -14.59% below its all-time high of $460.47 million, reached on 31 December 2023.EVH TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EVH Gross Profit Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | - | -20.6% | -14.6% |
3 y3 years | +83.9% | -3.8% | +57.0% |
5 y5 years | +164.5% | +203.2% | +125.9% |
EVH Gross Profit High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +83.9% | -35.1% | +14.9% | -14.6% | +57.0% |
5 y | 5 years | at high | +164.5% | -35.1% | +203.2% | -14.6% | +403.1% |
alltime | all time | at high | >+9999.0% | -35.1% | +203.2% | -14.6% |
Evolent Health Gross Profit History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $80.69 M(-24.5%) | $393.27 M(-10.0%) |
June 2024 | - | $106.84 M(+2.6%) | $437.01 M(-2.3%) |
Mar 2024 | - | $104.11 M(+2.4%) | $447.36 M(-2.8%) |
Dec 2023 | $460.47 M(+45.4%) | $101.63 M(-18.3%) | $460.47 M(+4.2%) |
Sept 2023 | - | $124.43 M(+6.2%) | $441.91 M(+9.5%) |
June 2023 | - | $117.20 M(-0.0%) | $403.44 M(+13.2%) |
Mar 2023 | - | $117.22 M(+41.1%) | $356.48 M(+12.6%) |
Dec 2022 | $316.58 M(+26.4%) | $83.06 M(-3.4%) | $316.58 M(-0.3%) |
Sept 2022 | - | $85.97 M(+22.4%) | $317.40 M(+9.2%) |
June 2022 | - | $70.23 M(-9.2%) | $290.77 M(+7.5%) |
Mar 2022 | - | $77.32 M(-7.8%) | $270.49 M(+8.0%) |
Dec 2021 | $250.41 M(+9.8%) | $83.88 M(+41.3%) | $250.41 M(+5.1%) |
Sept 2021 | - | $59.34 M(+18.8%) | $238.23 M(+0.6%) |
June 2021 | - | $49.94 M(-12.7%) | $236.70 M(-1.3%) |
Mar 2021 | - | $57.24 M(-20.2%) | $239.69 M(+5.1%) |
Dec 2020 | $228.06 M(+31.0%) | $71.70 M(+24.0%) | $228.06 M(+191.7%) |
Sept 2020 | - | $57.81 M(+9.2%) | $78.17 M(-28.1%) |
June 2020 | - | $52.94 M(+16.1%) | $108.74 M(-22.0%) |
Mar 2020 | - | $45.60 M(-158.3%) | $139.38 M(-19.9%) |
Dec 2019 | $174.09 M | -$78.18 M(-188.5%) | $174.09 M(-47.6%) |
Sept 2019 | - | $88.38 M(+5.7%) | $332.50 M(+3.9%) |
June 2019 | - | $83.58 M(+4.1%) | $320.10 M(+2.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2019 | - | $80.31 M(+0.1%) | $311.81 M(+4.2%) |
Dec 2018 | $299.24 M(+80.7%) | $80.22 M(+5.6%) | $299.24 M(+12.0%) |
Sept 2018 | - | $75.98 M(+0.9%) | $267.19 M(+15.7%) |
June 2018 | - | $75.30 M(+11.2%) | $230.85 M(+18.6%) |
Mar 2018 | - | $67.74 M(+40.6%) | $194.63 M(+17.5%) |
Dec 2017 | $165.60 M(+67.3%) | $48.18 M(+21.6%) | $165.60 M(+13.8%) |
Sept 2017 | - | $39.63 M(+1.4%) | $145.55 M(+10.1%) |
June 2017 | - | $39.08 M(+0.9%) | $132.22 M(+13.1%) |
Mar 2017 | - | $38.71 M(+37.6%) | $116.88 M(+18.0%) |
Dec 2016 | $99.01 M(+150.8%) | $28.13 M(+6.9%) | $99.01 M(+7.4%) |
Sept 2016 | - | $26.30 M(+10.8%) | $92.19 M(+13.1%) |
June 2016 | - | $23.74 M(+13.9%) | $81.53 M(+35.2%) |
Mar 2016 | - | $20.84 M(-2.2%) | $60.32 M(+52.8%) |
Dec 2015 | $39.48 M(>+9900.0%) | $21.31 M(+36.2%) | $39.48 M(+117.3%) |
Sept 2015 | - | $15.64 M(+519.1%) | $18.17 M(+619.1%) |
June 2015 | - | $2.53 M(>+9900.0%) | $2.53 M(>+9900.0%) |
Mar 2015 | - | $0.00(0.0%) | $0.00(-100.0%) |
Dec 2014 | $0.00(-100.0%) | $0.00(0.0%) | $5.25 M(0.0%) |
Sept 2014 | - | $0.00(0.0%) | $5.25 M(0.0%) |
June 2014 | - | $0.00(-100.0%) | $5.25 M(0.0%) |
Mar 2014 | - | $5.25 M | $5.25 M |
Dec 2013 | -$4.35 M | - | - |
FAQ
- What is Evolent Health annual gross profit?
- What is the all time high annual gross profit for Evolent Health?
- What is Evolent Health quarterly gross profit?
- What is the all time high quarterly gross profit for Evolent Health?
- What is Evolent Health quarterly gross profit year-on-year change?
- What is Evolent Health TTM gross profit?
- What is the all time high TTM gross profit for Evolent Health?
- What is Evolent Health TTM gross profit year-on-year change?
What is Evolent Health annual gross profit?
The current annual gross profit of EVH is $460.47 M
What is the all time high annual gross profit for Evolent Health?
Evolent Health all-time high annual gross profit is $460.47 M
What is Evolent Health quarterly gross profit?
The current quarterly gross profit of EVH is $80.69 M
What is the all time high quarterly gross profit for Evolent Health?
Evolent Health all-time high quarterly gross profit is $124.43 M
What is Evolent Health quarterly gross profit year-on-year change?
Over the past year, EVH quarterly gross profit has changed by -$20.93 M (-20.60%)
What is Evolent Health TTM gross profit?
The current TTM gross profit of EVH is $393.27 M
What is the all time high TTM gross profit for Evolent Health?
Evolent Health all-time high TTM gross profit is $460.47 M
What is Evolent Health TTM gross profit year-on-year change?
Over the past year, EVH TTM gross profit has changed by -$67.20 M (-14.59%)